489 related articles for article (PubMed ID: 26018796)
21. Ligand-induced regulation of ERalpha and ERbeta is indicative of human breast cancer cell proliferation.
Power KA; Thompson LU
Breast Cancer Res Treat; 2003 Oct; 81(3):209-21. PubMed ID: 14620916
[TBL] [Abstract][Full Text] [Related]
22. Proapoptotic and TRAIL-sensitizing constituents isolated from Salvia militiorrhiza (Danshen).
Chang CC; Lai JS; Tsai CS; Ma SW; Lin JY; Huang LR; Lu CH; Liao EC; Ho TF
J Biosci Bioeng; 2013 Oct; 116(4):516-23. PubMed ID: 23660075
[TBL] [Abstract][Full Text] [Related]
23. In vitro inhibitory effects of ethanol extract of Danshen (Salvia miltiorrhiza) and its components on the catalytic activity of soluble epoxide hydrolase.
Xu M; Hao H; Jiang L; Long F; Wei Y; Ji H; Sun B; Peng Y; Wang G; Ju W; Li P
Phytomedicine; 2015 Apr; 22(4):444-51. PubMed ID: 25925966
[TBL] [Abstract][Full Text] [Related]
24. Tanshinone IIA inhibits angiotensin II-induced cell proliferation in rat cardiac fibroblasts.
Chan P; Liu JC; Lin LJ; Chen PY; Cheng TH; Lin JG; Hong HJ
Am J Chin Med; 2011; 39(2):381-94. PubMed ID: 21476213
[TBL] [Abstract][Full Text] [Related]
25. Bioassays for estrogenic activity: development and validation of estrogen receptor (ERalpha/ERbeta) and breast cancer proliferation bioassays to measure serum estrogenic activity in clinical studies.
Li J; Lee L; Gong Y; Shen P; Wong SP; Wise SD; Yong EL
Assay Drug Dev Technol; 2009 Feb; 7(1):80-9. PubMed ID: 19382890
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of estrogenic/antiestrogenic activity of ellagic acid via the estrogen receptor subtypes ERalpha and ERbeta.
Papoutsi Z; Kassi E; Tsiapara A; Fokialakis N; Chrousos GP; Moutsatsou P
J Agric Food Chem; 2005 Oct; 53(20):7715-20. PubMed ID: 16190622
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of estrogenic/antiestrogenic activity of Onobrychis ebenoides extract - interaction with estrogen receptor subtypes ERalpha and ERbeta.
Papoutsi Z; Kassi E; Halabalaki M; Mitakou S; Moutsatsou P
Toxicol In Vitro; 2007 Apr; 21(3):364-70. PubMed ID: 17092687
[TBL] [Abstract][Full Text] [Related]
28. Acteoside and martynoside exhibit estrogenic/antiestrogenic properties.
Papoutsi Z; Kassi E; Mitakou S; Aligiannis N; Tsiapara A; Chrousos GP; Moutsatsou P
J Steroid Biochem Mol Biol; 2006 Jan; 98(1):63-71. PubMed ID: 16198557
[TBL] [Abstract][Full Text] [Related]
29. Tanshinone I effectively induces apoptosis in estrogen receptor-positive (MCF-7) and estrogen receptor-negative (MDA-MB-231) breast cancer cells.
Nizamutdinova IT; Lee GW; Son KH; Jeon SJ; Kang SS; Kim YS; Lee JH; Seo HG; Chang KC; Kim HJ
Int J Oncol; 2008 Sep; 33(3):485-91. PubMed ID: 18695877
[TBL] [Abstract][Full Text] [Related]
30. Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex.
Chen B; Gajdos C; Dardes R; Kidwai N; Johnston SR; Dowsett M; Jordan VC
Int J Oncol; 2005 Aug; 27(2):327-35. PubMed ID: 16010412
[TBL] [Abstract][Full Text] [Related]
31. Influence of cellular ERalpha/ERbeta ratio on the ERalpha-agonist induced proliferation of human T47D breast cancer cells.
Sotoca AM; van den Berg H; Vervoort J; van der Saag P; Ström A; Gustafsson JA; Rietjens I; Murk AJ
Toxicol Sci; 2008 Oct; 105(2):303-11. PubMed ID: 18644836
[TBL] [Abstract][Full Text] [Related]
32. Chemical Stability and Bioactivity of tanshinone I, tanshinone IIA, cryptotanshinone and dihydrotanshinone in in vitro test systems.
Roth A; Zhao P; Soukup ST; Guigas C; Stärke J; Kulling SE; Diel P
Toxicol Lett; 2023 Feb; 375():21-28. PubMed ID: 36563867
[TBL] [Abstract][Full Text] [Related]
33. [Effect of carnosol against proliferative activity of breast cancer cells and its estrogen receptor subtype's mediation and regulation mechanisms].
Zhao PW; Lee DY; Ma ZZ; Sun YL; Tao SY; Zang JF; Niu JZ
Zhongguo Zhong Yao Za Zhi; 2014 Sep; 39(17):3344-8. PubMed ID: 25522625
[TBL] [Abstract][Full Text] [Related]
34. Estrogen receptor-alpha-interacting cytokeratins potentiate the antiestrogenic activity of fulvestrant.
Long X; Fan M; Nephew KP
Cancer Biol Ther; 2010 Mar; 9(5):389-96. PubMed ID: 20061804
[TBL] [Abstract][Full Text] [Related]
35. Expression and role of estrogen receptor alpha and beta in medullary thyroid carcinoma: different roles in cancer growth and apoptosis.
Cho MA; Lee MK; Nam KH; Chung WY; Park CS; Lee JH; Noh T; Yang WI; Rhee Y; Lim SK; Lee HC; Lee EJ
J Endocrinol; 2007 Nov; 195(2):255-63. PubMed ID: 17951536
[TBL] [Abstract][Full Text] [Related]
36. Tanshinones from Salvia miltiorrhiza Bunge revert chemotherapy-induced neuropathic pain and reduce glioblastoma cells malignancy.
Di Cesare Mannelli L; Piccolo M; Maione F; Ferraro MG; Irace C; De Feo V; Ghelardini C; Mascolo N
Biomed Pharmacother; 2018 Sep; 105():1042-1049. PubMed ID: 30021339
[TBL] [Abstract][Full Text] [Related]
37. Calmodulin is a selective modulator of estrogen receptors.
García Pedrero JM; Del Rio B; Martínez-Campa C; Muramatsu M; Lazo PS; Ramos S
Mol Endocrinol; 2002 May; 16(5):947-60. PubMed ID: 11981030
[TBL] [Abstract][Full Text] [Related]
38. Tanshinone IIA, a constituent of Danshen, inhibits the release of glutamate in rat cerebrocortical nerve terminals.
Lin TY; Lu CW; Huang SK; Wang SJ
J Ethnopharmacol; 2013 May; 147(2):488-96. PubMed ID: 23542145
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta.
Escande A; Pillon A; Servant N; Cravedi JP; Larrea F; Muhn P; Nicolas JC; Cavaillès V; Balaguer P
Biochem Pharmacol; 2006 May; 71(10):1459-69. PubMed ID: 16554039
[TBL] [Abstract][Full Text] [Related]
40. Salvia miltiorrhiza: an ancient Chinese herbal medicine as a source for anti-osteoporotic drugs.
Guo Y; Li Y; Xue L; Severino RP; Gao S; Niu J; Qin LP; Zhang D; Brömme D
J Ethnopharmacol; 2014 Sep; 155(3):1401-16. PubMed ID: 25109459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
